Tag: Kenneth Anderson
-
Campus & Community
HMS, Dana-Farber scientists receive 2012 Alpert Prize
HMS faculty Kenneth Anderson, Paul Richardson, and Alfred Goldberg are three of four researchers being honored for their research and development of a pioneering cancer drug.
-
Health
Cancer drug activates adult stem cells
The use of a drug used in cancer treatment activates stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment…
-
Health
Scientists discover new genetic subtypes of common blood cancer
Scientists at Dana-Farber Cancer Institute and collaborators have identified four distinct genetic subtypes of multiple myeloma, a deadly blood cancer, that have different prognoses and might be treated most effectively…
-
Health
Novel combination overcomes drug-resistant multiple myeloma cells
The researchers hope to move rapidly to clinical trials of the therapy, a combination of the drug Velcade and an experimental compound that was designed by researchers at the Broad…
-
Campus & Community
New cancer drug wins FDA approval
When he was a first-year student at Harvard Medical School, Alfred Goldberg, now a professor of cell biology, wondered why the body destroys its own proteins, which are so vital…